Lat­est J&J-part­nered Leg­end Biotech da­ta spot­light con­tin­ued high re­sponse rate but 10 pa­tient deaths

Leg­end Biotech has has a good three years ever since the then-lit­tle known biotech un­veiled a round of BC­MA CAR-T da­ta at AS­CO. It …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.